$470 Million is the total value of Capital Advantage, Inc.'s 40 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VCIT | New | Vanguard Intermediate Term Corporate ETFetf | $36,188,211 | – | 448,874 | +100.0% | 7.70% | – |
WDAY | New | Workday Incequities | $4,540,671 | – | 22,412 | +100.0% | 0.97% | – |
VYM | New | Vanguard High Dividend Yield ETFetf | $1,081,989 | – | 10,272 | +100.0% | 0.23% | – |
PCG | New | PG&E Corpequities | $245,160 | – | 15,199 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp | 39 | Q3 2023 | 1.2% |
Chevron Corp | 39 | Q3 2023 | 1.0% |
Facebook Inc Class A | 39 | Q3 2023 | 1.3% |
AT&T Inc | 39 | Q3 2023 | 0.6% |
Pfizer Incorporated | 39 | Q3 2023 | 0.3% |
Cisco Systems Inc | 39 | Q3 2023 | 0.3% |
Verizon Communications Inc | 39 | Q3 2023 | 0.3% |
iShares Russell 2000 ETF | 38 | Q2 2023 | 1.4% |
Vanguard Dividend Appreciation ETF | 37 | Q3 2023 | 8.4% |
Merck & Co Inc | 37 | Q2 2023 | 0.4% |
View Capital Advantage, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-30 |
13F-HR | 2023-08-07 |
13F-HR | 2023-05-05 |
13F-HR | 2023-01-24 |
13F-HR | 2022-10-31 |
13F-HR | 2022-07-21 |
13F-HR | 2022-05-10 |
13F-HR | 2022-01-21 |
View Capital Advantage, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.